HIGHLIGHTS
- who: Xiaowen Qi and collaborators from the University of Texas MD Anderson have published the research: Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer, in the Journal: (JOURNAL)
- future: Ferroptosis offers a new direction in the treatment of breast cancer but how to avoid its side effects is still an open question.
SUMMARY
Nuclear factor erythroid 2-related factor 2 (NRF2) exerts its antioxidant effects by upregulating the expression of genes related to iron and ROS metabolism and HO-1 to reduce ROS levels, increasing chemoresistance and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.